- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.06. | Axsome fends off generic competition to narcolepsy med Sunosi until 2040 | ||
| 04.06. | Medline earns FDA warning letter ire for repeated toxic bacteria problems | ||
| 03.06. | A patient-first shift in disease language and communication | ||
| 03.06. | Lilly, Boehringer to slash at least $1B each from planned investments in Germany | ||
| 03.06. | Coffee, racetracks, beaches and more coffee-inside the ASCO 2026 exhibit floor | ||
| 03.06. | Amid Miplyffa launch, Zevra CEO aims to foster EU-style Niemann-Pick market in US | ||
| 03.06. | With Cencora pact, Gilead looks to grow CAR-T treatment center network | ||
| 03.06. | FDA issues untitled letter after finding 'eye-catching graphics' in promotional emails | ||
| 03.06. | Neurotech launches new YouTube channel to spotlight patients' stories for rare eye disorder | ||
| 02.06. | Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts | ||
| 02.06. | Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances | ||
| 02.06. | Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population | ||
| 02.06. | Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens: report | ||
| 02.06. | Sanofi taps Snowflake for AI field agent help | ||
| 02.06. | ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection | ||
| 02.06. | Eisai whips up Alzheimer's dietary guidance to expand nutrition program beyond cancer | ||
| 02.06. | Regulatory tracker: J&J grows Tremfya label stateside; AbbVie nets EU Venclyxto expansion | ||
| 01.06. | How HER2 biology is shaping next-generation cancer treatment | ||
| 01.06. | Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative | ||
| 01.06. | ViiV Healthcare launches 'PrEP Wisdom' campaign to boost awareness of long-acting HIV prevention meds | ||
| 31.05. | ASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% | ||
| 29.05. | Pharma urged to modernize patient support as young adult cancer rates rise | ||
| 29.05. | Philips adds a spoonful of Disney sugar to ease kids' MRI anxieties | ||
| 28.05. | AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi | ||
| 28.05. | Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.